ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0959

Growing Challenge of Inadequate Kidney Biopsies: Quantifying the Problem and Effect on Nephropathology Practice

Session Information

Category: Pathology and Lab Medicine

  • 1800 Pathology and Lab Medicine

Authors

  • Caza, Tiffany, Arkana Laboratories, Little Rock, Arkansas, United States
  • Tidwell, Whitney, Arkana Laboratories, Little Rock, Arkansas, United States
  • Ferrell, Veronica, Arkana Laboratories, Little Rock, Arkansas, United States
  • Larsen, Christopher Patrick, Arkana Laboratories, Little Rock, Arkansas, United States
  • Walker, Patrick D., Arkana Laboratories, Little Rock, Arkansas, United States
Background

A kidney biopsy is critical for the diagnosis and management of medical renal disease, yet biopsy adequacy has become a significant problem. The number of biopsies with <10 glomeruli by light microscopy has markedly risen, with frequency of 1% in 2005, 13% in 2018, and has continued to increase. Standard of care for an adequate biopsy is sufficient tissue for diagnosis, treatment and prognostic information, and ancillary studies. Here, we characterize biopsy adequacy from a consecutive cohort of 82,919 cases.

Methods

Kidney biopsy data (including glomerular counts, percent cortex, and ancillary studies) from cases received from 2020-2024 were evaluated from a biopsy database at Arkana Laboratories (n=82,919, comprising 69,808 native and 13,111 transplant cases). There are no established criteria for adequacy for native kidney biopsies, however, multiple pathologic scoring systems require approximately 10 glomeruli for assessment. Therefore, we define an adequate biopsy as having ≥10 glomeruli by light microscopy and ≥5 glomeruli for immunofluorescence (IF). We evaluated the frequency of inadequate biopsies by type, demographics, utilization of ancillary studies, and residence in health professional shortage areas (HPSAs). Chi-Square analysis was used to compare differences.

Results

Of 82,919 biopsies, 34,562 were inadequate (41.7%). There was a similar rate of inadequacy in both native and transplant cases (41.8 vs. 41.3%, p=0.87). There was a slight increase in inadequate biopsies in males (42.3 vs. 41.0%, p<0.0001), and lower rates of inadequate biopsies among children than adults (34.0% vs. 42.0 %, p=0.0029). There was no impact of residence in HPSA zip codes (68.4% vs. 68.4%, p=1.0).

Inadequate biopsies were more often deep with <50% cortex (40.5 vs. 7.5%, p<0.0001), within both native and transplant cases. There was a significant increase in utilization of salvage studies, including deeper tissue sections (18.2% vs. 6.4%, p<0.0001) or paraffin IF (23.6% vs. 9.8%, p<0.0001). There were significantly more inadequate cases without electron microscopy (16.1% vs. 5.9%, p<0.0001).

Conclusion

Inadequate kidney biopsies are increasingly common in both the native and transplant setting, resulting in limitations in diagnosis and increased healthcare costs.

Digital Object Identifier (DOI)